Merck Provides Update on Next Steps for Tredaptive (extended-release niacin/laropiprant)

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Jan 11, 2013 - Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the company is taking steps to suspend the availability of TREDAPTIVE™...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news